ReferIndia News Canada's Green Light to Apotex's Ozempic Generic

ReferIndia News

Want to grow your business digitally?

Let us help you get there—fast, smart, and effective.

Contact Now
News Image

Canada's Green Light to Apotex's Ozempic Generic

Published on: May 2, 2026, 1:15 a.m. | Source: Devdiscourse

The Canadian health regulator has approved Apotex's generic version of semaglutide, marking it as the second authorized generic version of Novo Nordisk's popular diabetes drug, Ozempic, in Canada.

Checkout more news
Ad Banner

Loans & Investments—All with Kunjesh

Business, Home, Mortgage, Personal Loans + Expert Investment Banking. Trusted since 2001. Quick approvals.

Get Started
ReferIndia News contact